DnB Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
DnB Asset Management's BIO Position: Q3 2026 in Review
DnB Asset Management held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2026 at 1,229 shares worth $464K. The position accounts for ﹤0.01% of the portfolio, ranked #805.
DnB Asset Management first reported a position in BIO in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.13M in Q4 2024. 417 funds tracked by Wall St. Rank hold BIO as of Q3 2026.
- DnB Asset Management held 1,229 shares of Bio-Rad Laboratories Class A worth $464K as of Q3 2026.
- DnB Asset Management left its Bio-Rad Laboratories Class A share count unchanged in Q3 2026.
- Bio-Rad Laboratories Class A made up ﹤0.01% of DnB Asset Management's portfolio in Q3 2026, its #805 holding.
- DnB Asset Management first reported a position in Bio-Rad Laboratories Class A in Q1 2024 and has held it in 8 quarters since.
- DnB Asset Management's Bio-Rad Laboratories Class A position peaked at $1.13M in Q4 2024.
- 417 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.
Based on DnB Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.